Hospital horizontal and vertical consolidation has a number of pernicious effects. One is described in a Milliman report on cancer care costs. (Milliman Report) The researchers compared costs for non-small cell lung cancer, colorectal cancer and breast cancer patients receiving either adjuvant chemotherapy or metastatic chemotherapy at a physician’s office versus in a hospital outpatient setting. The data source was a commercial claims database for the years 2009 and 2010 and the comparisons were adjusted for various patient characteristics. The lowest difference was for adjuvant therapy for colorectal cancer at a mere 28% more for hospital outpatient treatment and the highest was for metastatic chemotherapy for colorectal cancer, 53% higher. Adjuvant breast cancer therapy and metastatic lung cancer treatment were both around 50% higher in the hospital setting. No treatment was cheaper. Hospital ownership of oncology practices has increased rapidly, with one source predicting it will be 42% by 2015, and the incentive to move treatment to the hospital outpatient setting is obvious. Hospital facility charges are very high and unit costs for drugs are at least twice as high. In most cases, there is no reason why patients cannot be treated in a physician’s office and the much greater cost of hospital outpatient services also usually means higher cost-sharing for the patient. MedPAC has been urging CMS for years to equalize the payments for the same service across settings. Commercial payers seldom have the leverage CMS has in regard to hospitals. This is blatant abuse of market power which just wastes money. While cancer patients make up a small part of the commercial population, they obviously have disproportionate costs, and paying only the physician office rates, regardless of setting, would result in significant savings. If necessary, policymakers should enact legislation or rules to equalize payments and end this unnecessarily expensive effect of the hospital system aggregation of providers.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
More on Deaths and Causes
October 4, 2024
More on Deaths and Causes
An ongoing study examines the global burden of disease, including causes of death.
Commentary
Real Temperature Trends
October 3, 2024
Real Temperature Trends
New methods again demonstrate that we are currently in a cool period and there is…
Commentary
Election Observations
October 3, 2024
Election Observations
Little Timmy Walz revealed his lying, incompetent self on the debate stage.